Baseline characteristics

Cellular Therapy With Cord Blood Cells · Source last updated 2012-05-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      30

   units

   Participants

groups

1. description

   Fludarabine 30 mg/m\^2 intravenous (IV) for 4 Days + Melphalan 140 mg/m\^2 IV for 1 Day + Rituximab 375 mg/m\^2 IV once weekly + Cord Blood Transplantation + Stem Cell Transplantation Infusion

   id

   BG000

   title

   Cellular Therapy With Cord Blood Cells

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            17

            value

            44

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            11

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            19

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            30

      title

      United States

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice